Figure 1.
Effect of cisplatin and resveratrol on the viability of MDA231 cells. (A) Cell survival rate treated by cisplatin; (B) cell survival rate treated by resveratrol for 24, 48, and 72 h; (C) cell survival rate treated by 14 μM cisplatin combined with different concentrations of resveratrol for 24 h; (D) CI value of cisplatin 14 μM combined with resveratrol treatment; (E) cell survival rate treated by 185 μM resveratrol combined with different concentrations of cisplatin for 24 h; (F) CI value of 185 μM resveratrol combined with cisplatin treatment. The experiment was repeated three times, RES, resveratrol. CIS, cisplatin. * p < 0.05, ** p < 0.01, vs. the control group.
